Quantinno Capital Management LP grew its holdings in National Research Corporation (NASDAQ:NRC – Free Report) by 61.3% during the 1st quarter, HoldingsChannel reports. The firm owned 62,329 shares of the company’s stock after acquiring an additional 23,682 shares during the quarter. Quantinno Capital Management LP’s holdings in National Research were worth $1,058,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. M&T Bank Corp lifted its position in shares of National Research by 6.4% during the 2nd quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after purchasing an additional 823 shares during the last quarter. Sei Investments Co. boosted its stake in National Research by 1.2% during the 3rd quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock valued at $975,000 after purchasing an additional 900 shares during the period. Russell Investments Group Ltd. grew its holdings in National Research by 85.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after buying an additional 921 shares during the last quarter. Invesco Ltd. grew its holdings in National Research by 6.3% in the 2nd quarter. Invesco Ltd. now owns 17,368 shares of the company’s stock valued at $292,000 after buying an additional 1,022 shares during the last quarter. Finally, Alliancebernstein L.P. increased its position in National Research by 6.3% in the 3rd quarter. Alliancebernstein L.P. now owns 18,499 shares of the company’s stock worth $236,000 after buying an additional 1,100 shares during the period. 47.26% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on NRC shares. Citizens Jmp upped their price target on National Research from $23.00 to $26.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 29th. Wall Street Zen downgraded shares of National Research from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Weiss Ratings lowered shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, August 6th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, National Research currently has a consensus rating of “Hold” and an average target price of $26.00.
National Research Stock Down 0.6%
NASDAQ NRC opened at $21.19 on Friday. National Research Corporation has a 1-year low of $11.01 and a 1-year high of $23.68. The company has a market capitalization of $482.07 million, a price-to-earnings ratio of 84.76 and a beta of 0.34. The stock’s 50 day moving average is $20.63 and its two-hundred day moving average is $18.24. The company has a current ratio of 0.65, a quick ratio of 0.65 and a debt-to-equity ratio of 13.13.
National Research (NASDAQ:NRC – Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.46. The business had revenue of $35.39 million during the quarter, compared to analysts’ expectations of $34.90 million. National Research had a return on equity of 164.26% and a net margin of 4.18%.
National Research Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 9th. Shareholders of record on Friday, September 25th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date is Friday, September 25th. National Research’s dividend payout ratio is 256.00%.
National Research Profile
National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.
Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.
Read More
- Five stocks we like better than National Research
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Corporation (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
